Skip to main content

Pharma News

Crack GPAT — Prepare for GPAT Online 

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Tau protein can be focal point for future drug therapies in Alzheimers

    Novel discovery has revealed how the tau protein, a critical element in the formation of Alzheimers disease, is also involved in normal learning processes in the healthy brain, potentially providing a focal point for future drug therapies.

    Employing a sensitive method named proximity labelling, the team aimed to identify all proteins that tau comes in contact with within brain cells, labelling and identifying the whole collection of interacting proteins as they went.

  • Axsome Therapeutics announces FDA Approval of AUVELITY

    Axsome Therapeutics, Inc a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved AUVELITYTM (dextromethorphan HBr -bupropion HCl) extended-release tablets for the treatment of major depressive disorder (MDD) in adults.

  • Unichem Laboratories Limited receives USFDA approval for Carbamazepine Tablets USP

    Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world. In India, The Company has strong skills in product development, process chemistry and manufacturing complex API as well as dosage forms.

  • Johnson & Johnson will stop selling 128 years old Talc-based baby powder

    Johnson & Johnson has announced that it will discontinue talc-based baby powder worldwide after two years of withdrawing sell of talc-based baby powder in the United States and Canada. The company will stop selling the product in the global market from 2023.

  • FDA found cancer causing impurity in anti-diabetic medicine

    FDA found out cancer causing impurity in commonly used anti-diabetic medicines,  sitagliptin and notified in Drug safety report. FDA recently became aware of a nitrosamine impurity, Nitroso-STG-19 (known as NTTP), in certain samples of sitagliptin, a medicine used to treat type 2 diabetes mellitus.

  • Zydus receives final approval from the USFDA for Prochlorperazine Maleate Tablets

    Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Prochlorperazine Maleate tablets, USP 5 mg and 10 mg.

    Prochlorperazine tablets are used to treat nervous, emotional, and mental conditions (eg. schizophrenia) and non-psychotic anxiety. It is also used to control severe nausea and vomiting. The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India.

  • Future medical applications in drug design Research team studies role morphogens play in tissue patterning in heart development

    Morphogens are molecules that travel from biological cell to cell to pattern tissues in the embryo. These molecules are important not only for the embryo during development, but also for the adult during tissue repair. However, the way these morphogens are distributed to ensure patterning occurs is still not fully understood.

  • A role for cell antennae in managing dopamine signals in the brain

    A historically overlooked rod-like projection present on nearly every cell type in the human body may finally be getting its scientific due: A new study has found that these appendages, called cilia, on neurons in the brain have a key role in ensuring a specific dopamine receptor’s signals are properly received.

  • Body Posture Affects How Oral Drugs Absorbed by Stomach

    A common, economic, and easy method of administering drugs is orally, by swallowing a pill or capsule. But oral administration is the most complex way for the human body to absorb an active pharmaceutical ingredient, because the bioavailability of the drug in the gastrointestinal tract depends on the medication’s ingredients and the stomach’s dynamic physiological environment.

  • IIHMR University, Jaipur confers 278 students with degrees during Convocation 2022

    The IIHMR University, Jaipur hosted its annual convocation on August 6 2022 for PhD Program and the two year (MBA Hospital and Health Management, MBA Pharmaceutical Management, MBA Rural Management) programs. On this occasion Shri VP Agarwal Gold Medal and Silver Medal has been awarded to students of all programs in recognition of their academic excellence.

Subscribe to Pharma News